Injectable hydrogel system prolongs joint retention in osteoarthritis
Osteoarthritis is a leading cause of chronic pain and disability worldwide. Current intra-articular standards of care, such as analgesics, corticosteroids and viscosupplements, provide only transient symptomatic relief and do not reliably modify disease progression. A major translational barrier is the rapid clearance of small-molecule drugs and biologics from synovial fluid, as well as the…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
